ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,230, issued on Aug. 5, was assigned to Pfizer Inc. (New York).
"GLP-1 receptor agonists and uses thereof" was invented by Gary Erik Aspnes (Biberach an der Riss, Germany), Scott W. Bagley (Voluntown, Conn.), John M. Curto (Mystic, Conn.), David James Edmonds (Riehen, Switzerland), Mark E. Flanagan (Gales Ferry, Conn.), Kentaro Futatsugi (Sharon, Mass.), David A. Griffith (Sudbury, Mass.), Kim Huard (Berkeley, Calif.), Yajing Lian (Waterford, Conn.), Chris Limberakis (Pawcatuck, Conn.), Allyn T. Londregan (Barrington, R.I.), Alan M. Mathiowetz (Waltham, Mass.), David W. Piotrowski (Waterford, Conn.) and Roger B. Ruggeri (Waterford, Conn.).
According to the abstract* released by the...